Ignite Creation Date:
2024-05-06 @ 7:51 AM
Last Modification Date:
2024-10-26 @ 11:53 AM
Study NCT ID:
NCT02610777
Status:
COMPLETED
Last Update Posted:
2022-09-19
First Post:
2015-11-18
Brief Title:
An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes HR MDS Chronic Myelomonocytic Leukemia CMML and Low-Blast Acute Myelogenous Leukemia AML
Sponsor:
Millennium Pharmaceuticals Inc
Organization:
Takeda
Organization Data
Organization:
Takeda
Class:
INDUSTRY
Study ID:
Pevonedistat-2001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Millennium Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None